These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 20542848)
21. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Checking up on ddI and tenofovir in people with HIV/AIDS. TreatmentUpdate; 2003; 15(3):4-5. PubMed ID: 17216846 [No Abstract] [Full Text] [Related]
22. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Molina JM; Cahn P; Grinsztejn B; Lazzarin A; Mills A; Saag M; Supparatpinyo K; Walmsley S; Crauwels H; Rimsky LT; Vanveggel S; Boven K; Lancet; 2011 Jul; 378(9787):238-46. PubMed ID: 21763936 [TBL] [Abstract][Full Text] [Related]
23. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine. Redfield RR; Morrow JS Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234 [No Abstract] [Full Text] [Related]
24. Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study. Semvua HH; Mtabho CM; Fillekes Q; van den Boogaard J; Kisonga RM; Mleoh L; Ndaro A; Kisanga ER; van der Ven A; Aarnoutse RE; Kibiki GS; Boeree MJ; Burger DM Antivir Ther; 2013; 18(1):105-13. PubMed ID: 23043067 [TBL] [Abstract][Full Text] [Related]
25. Raltegravir as effective as efavirenz in 144-week data. AIDS Patient Care STDS; 2009 Aug; 23(8):679-80. PubMed ID: 19694035 [No Abstract] [Full Text] [Related]
26. Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman. Kiyasu Y; Koganemaru H; Hitomi S J Infect Chemother; 2012 Apr; 18(2):255-7. PubMed ID: 21918819 [TBL] [Abstract][Full Text] [Related]
27. Should tenofovir ever be used in association with didanosine? Diaz RS Braz J Infect Dis; 2005 Dec; 9(6):452-3. PubMed ID: 16410938 [No Abstract] [Full Text] [Related]
28. [3 years' data of tenofovir. Confirmed as a valuable building block]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():30-1. PubMed ID: 15373042 [No Abstract] [Full Text] [Related]
29. Safety, efficacy, and persistence of emtricitabine/tenofovir versus other nucleoside analogues in naive subjects aged 50 years or older in Spain: the TRIP study. Blanco JR; Caro-Murillo AM; Castaño MA; Olalla J; Domingo P; Arazo P; Gómez-Sirvent JL; Riera M; Pulido F; Vera F; Romero-Palacios A; Aguirrebengoa K; Portilla J; Ferrer P; Pedrol E HIV Clin Trials; 2013; 14(5):204-15. PubMed ID: 24144897 [TBL] [Abstract][Full Text] [Related]
30. The first once-daily single-tablet regimen for the treatment of HIV-infected patients. Killingley B; Pozniak A Drugs Today (Barc); 2007 Jul; 43(7):427-42. PubMed ID: 17728844 [TBL] [Abstract][Full Text] [Related]
31. Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults. Martínez E; Milinkovic A; de Lazzari E; Ravasi G; Blanco JL; Larrousse M; Mallolas J; García F; Miró JM; Gatell JM Lancet; 2004 Jul 3-9; 364(9428):65-7. PubMed ID: 15234858 [TBL] [Abstract][Full Text] [Related]
32. Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. Haskelberg H; Hoy JF; Amin J; Ebeling PR; Emery S; Carr A; STEAL Study Group PLoS One; 2012; 7(6):e38377. PubMed ID: 22719882 [TBL] [Abstract][Full Text] [Related]
33. Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all? Goicoechea M; Best B Expert Opin Pharmacother; 2007 Feb; 8(3):371-82. PubMed ID: 17266471 [TBL] [Abstract][Full Text] [Related]
38. Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results. Reynes J; Lawal A; Pulido F; Soto-Malave R; Gathe J; Tian M; Fredrick LM; Podsadecki TJ; Nilius AM HIV Clin Trials; 2011; 12(5):255-67. PubMed ID: 22180523 [TBL] [Abstract][Full Text] [Related]
39. Symfi, Symfi Lo, and Cimduo for HIV. Med Lett Drugs Ther; 2019 Jan; 61(1563):e8-e10. PubMed ID: 30681663 [No Abstract] [Full Text] [Related]